Formulary product proposals should include three-year cost-impact assessments.
Executive Summary
FORMULARY LISTED PRODUCTS SHOULD HAVE THREE-YEAR COST-IMPACT ASSESSMENTS, according to pharmacoeconomic guidelines for managed care organizations developed by Paul Langley, PhD, University of Arizona-Tuscon, and Sean Sullivan, PhD, University of Washington-Seattle. The guidelines are published in the November/December issue of the Academy of Managed Care Pharmacy's Journal of Managed Care Pharmacy.